Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ZVSA | US
0
0%
Healthcare
Biotechnology
30/06/2024
21/10/2024
2.30
2.25
2.34
2.13
ZyVersa Therapeutics Inc. a clinical stage biopharmaceutical company develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200 a cholesterol efflux mediator which is in Phase 2a clinical trial to the treatment of multiple renal indications such as focal segmental glomerulosclerosis alport syndrome and diabetic nephropathy; and IC 100 a monoclonal antibody inflammasome ASC inhibitor that is in preclinical stage for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics Inc. is headquartered in Weston Florida.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
22.4%1 month
29.1%3 months
90.9%6 months
118.9%0.00
-
0.29
-
-
-2.21
-
-
-10.25M
2.47M
2.47M
-
-
-
-
-152.23
0.32
2.22
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.48
Range1M
0.58
Range3M
2.30
Rel. volume
1.04
Price X volume
333.45K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Salarius Pharmaceuticals Inc | SLRX | Biotechnology | 1.82 | 2.62M | -9.45% | n/a | 0.00% |
Dermata Therapeutics Inc. Common Stock | DRMA | Biotechnology | 1.56 | 2.36M | -3.11% | n/a | 0.00% |
Allarity Therapeutics Inc. Common Stock | ALLR | Biotechnology | 1.63 | 2.30M | -5.78% | n/a | 6.68% |
Altamira Therapeutics Ltd. | CYTO | Biotechnology | 0.5751 | 2.17M | -2.53% | 0.32 | 1.54% |
60 Degrees Pharmaceuticals Inc. Common Stock | SXTP | Biotechnology | 1.07 | 1.99M | -1.83% | n/a | 5.19% |
Sorrento Therapeutics Inc | SRNE | Biotechnology | 0.003 | 1.90M | 11.11% | n/a | -101.21% |
Panbela Therapeutics Inc | PBLA | Biotechnology | 0.3354 | 1.76M | 5.14% | 0.00 | -39.69% |
Kiromic BioPharma Inc | KRBP | Biotechnology | 1.1 | 1.70M | -8.33% | n/a | -258.59% |
Innovation Pharmaceuticals Inc | IPIX | Biotechnology | 0.003 | 1.56M | 200.00% | n/a | 20.48% |
CohBar Inc | CWBR | Biotechnology | 0.5 | 1.45M | 0.00% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.65 | 2.01M | -6.89% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -2.21 | 0.53 | Cheaper |
Ent. to Revenue | - | 3,967.00 | - |
PE Ratio | 0.00 | 41.03 | Cheaper |
Price to Book | 0.29 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 90.90 | 72.80 | Riskier |
Debt to Equity | - | -1.23 | - |
Debt to Assets | - | 0.25 | - |
Market Cap | 2.47M | 3.66B | Emerging |